ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentLausanneAC Immune SA
AC Immune SA Logo
Verified· 3 sources

AC Immune SA

Summary

About the company

The core activity of AC Immune SA is the development of therapeutics for neurodegenerative diseases, particularly Alzheimer's disease, and other central nervous system disorders. The company focuses on researching, developing and commercializing innovative medicines and therapies in collaboration with leading pharmaceutical and biotechnology companies, academic institutions and patient organizations.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered6
Precision medicine for neurodegenerative diseases
Precision medicine approaches for Alzheimer’s, Parkinson’s and selected rare neurodegenerative diseases; integrated diagnostics and therapeutics to monitor disease-specific proteinopathies and select the appropriate treatment.
Antibody and active immunotherapies
Active immunotherapies and monoclonal antibodies against misfolded proteins such as Tau, amyloid-beta, alpha-synuclein and TDP-43; developed for Alzheimer’s, Parkinson’s and NeuroOrphan indications.
Small-molecule aggregation inhibitors
Small-molecule agents to inhibit intracellular protein aggregates, in particular Tau and alpha-synuclein aggregation, with candidates for Alzheimer’s, Parkinson’s and neuroinflammatory targets.
Diagnostic PET tracers
PET imaging tracers for reliable detection of pathological protein deposits, in particular Tau and alpha-synuclein targets, for early diagnosis and biomarker-based study planning.
NLRP3 inhibitors for neuroinflammation
Small molecules and antibodies to inhibit the NLRP3 inflammasome pathway in CNS and non-CNS indications, with a focus on neuroinflammatory disease mechanisms.
Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 2 reviews across all connected sources

Sources
GGoogle52
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once AC Immune SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

AC Immune SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank AC Immune SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of AC Immune SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

EPFL
1015 Lausanne

At a glance

Legal form
Corporation
UID
CHE-109.878.825
Founded
2003 · 23 years
Last commercial register change
July 15, 2026
Employees
101 to 500

Similar companies

BT
bNovate Technologies SA
Ecublens Vd
SS
Swisslabnat Sàrl
Lutry
SS
Synature SA
Lausanne
TS
Topodrone SA
Montreux